share_log

Virpax Pharmaceuticals | 8-K: Current report

Virpax Pharmaceuticals | 8-K: Current report

Virpax製藥 | 8-K:重大事件
美股SEC公告 ·  07/30 17:31
Moomoo AI 已提取核心訊息
Virpax Pharmaceuticals, Inc. received an extension from Nasdaq on July 29, 2024, to regain compliance with the minimum stockholders' equity requirement by September 30, 2024. The company had previously been notified of noncompliance due to its stockholders' equity falling below the required $2.5 million as of December 31, 2023. Additionally, during the 2024 Annual Meeting held on the same day, shareholders approved two amendments to the 2022 Equity Incentive Plan, increasing the number of shares available for grant and the annual 'evergreen provision' percentage. Eric Floyd and Gary Herman were elected as Class III directors, and EisnerAmper, LLP was ratified as the independent registered public accounting firm for the year ending December 31, 2024.
Virpax Pharmaceuticals, Inc. received an extension from Nasdaq on July 29, 2024, to regain compliance with the minimum stockholders' equity requirement by September 30, 2024. The company had previously been notified of noncompliance due to its stockholders' equity falling below the required $2.5 million as of December 31, 2023. Additionally, during the 2024 Annual Meeting held on the same day, shareholders approved two amendments to the 2022 Equity Incentive Plan, increasing the number of shares available for grant and the annual 'evergreen provision' percentage. Eric Floyd and Gary Herman were elected as Class III directors, and EisnerAmper, LLP was ratified as the independent registered public accounting firm for the year ending December 31, 2024.
Virpax藥品公司於2024年7月29日獲得納斯達克的延期,以便在2024年9月30日之前恢復符合最低股東權益要求。此前,該公司因股東權益低於2023年12月31日要求的250萬美元而被通知不符合要求。此外,在同一天舉行的2024年年度股東大會上,股東批准了兩項對2022年權益激勵計劃的修正案,增加了可用於授予的股票數量和年度“常青條款”比例。埃裏克·弗洛伊德和加里·赫爾曼被選爲三等類董事,EisnerAmper,LLP被確認爲獨立註冊公共會計師事務所,截至2024年12月31日。
Virpax藥品公司於2024年7月29日獲得納斯達克的延期,以便在2024年9月30日之前恢復符合最低股東權益要求。此前,該公司因股東權益低於2023年12月31日要求的250萬美元而被通知不符合要求。此外,在同一天舉行的2024年年度股東大會上,股東批准了兩項對2022年權益激勵計劃的修正案,增加了可用於授予的股票數量和年度“常青條款”比例。埃裏克·弗洛伊德和加里·赫爾曼被選爲三等類董事,EisnerAmper,LLP被確認爲獨立註冊公共會計師事務所,截至2024年12月31日。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息